We subsequently discovered that miR-548ag is upregulated in obese individuals and contributes to glucose metabolism disorders by targeting DNMT3B, thereby upregulating DPP4 expression in the liver. The gene discussed is DNMT3B; the disease is glucose metabolism disease.